Proven Experience Driving CNS research and drug development

---

Neuro-Xplore, led by Nathalie Picard, PhD, brings over 20 years of neuroscience and neuropharmacology expertise to advance research in CNS disorders, rare neurological diseases, and psychiatric conditions. Nathalie has led more than 15 preclinical programs, supporting go/no-go decisions, study design, and translational insights that bridge discovery to clinical development.

We specialize in:

• CNS drug development and mechanism of action studies
• Robust preclinical study design with clear endpoints and go/no-go criteria
• CRO management, including selection, oversight, and quality control
• Data analysis and strategic reporting to guide informed decisions
   

We also aim to support family foundations and patient organizations by translating complex science into actionable insights, exploring research opportunities, and fostering collaborations to advance progress.